Ernexa Therapeutics Inc. Sales and Excise Tax Payable, Current
Ernexa Therapeutics Inc. (ERNA) had Sales and Excise Tax Payable, Current of $6.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Taxes Payable, Current
us-gaap:SalesAndExciseTaxPayableCurrent · last filed 2021-03-11
- 2020-12-31: Sales and Excise Tax Payable, Current $6.00K.
- 2020-09-30: Sales and Excise Tax Payable, Current $14.00K.
- 2020-03-31: Sales and Excise Tax Payable, Current $19.00K.
- 2019-12-31: Sales and Excise Tax Payable, Current $131.00K.
| Period end | Sales and Excise Tax Payable, Current |
|---|---|
| 2020-12-31 | $6.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $14.00K 10-Q · filed 2020-11-13 |
| 2020-03-31 | $19.00K 10-Q · filed 2020-05-20 |
| 2019-12-31 | $131.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $71.00K 10-Q · filed 2019-11-01 |
| 2019-06-30 | $67.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $77.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $87.00K 10-K · filed 2020-03-19 |
| 2018-09-30 | $137.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $110.00K 10-Q · filed 2018-08-06 |
| 2018-03-31 | $92.00K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $107.00K 10-K · filed 2019-03-22 |
| 2017-09-30 | $89.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $95.00K 10-Q · filed 2017-08-04 |
| 2017-03-31 | $101.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $142.00K 10-K · filed 2018-03-09 |
| 2016-09-30 | $155.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $114.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $129.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $192.00K 10-K · filed 2017-03-09 |
| 2014-12-31 | $133.00K 10-K · filed 2016-03-15 |
| 2014-09-30 | $26.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $27.00K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $26.00K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $27.00K 10-Q · filed 2014-11-07 |
| 2013-09-30 | $29.00K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $29.00K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $29.00K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $70.00K 10-Q · filed 2013-11-14 |
| 2012-09-30 | $450.00K 10-Q · filed 2012-11-09 |
| 2011-12-31 | $604.00K 10-Q · filed 2012-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |